Skip to content

Automating Breast Radiation Therapy (RT)

Automating the Breast Radiation Therapy Process to Improve Efficiency

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00923871
Enrollment
160
Registered
2009-06-18
Start date
2009-06-30
Completion date
2016-04-29
Last updated
2022-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

CBCT, Breast Cancer

Brief summary

Breast radiation treatment is planned from a Computed Tomography (CT) scan. This study is designed to investigate a method to reduce the time between the planning of radiation treatment and its actual start by automating the intensity-modulated radiation therapy (IMRT) planning process. The investigators plan to examine data from another scan called Cone Beam Computed Tomography (CBCT). A CBCT scan provides similar information to a conventional CT scan, however the images for CBCT are acquired at the treatment unit (linear accelerator used for treatment). Using these x-ray pictures of patients, the study team consisting of a radiation oncologist, a medical physicist and a radiation therapist will create a custom treatment plan unique to each patient. By doing this, the investigators hope to reduce the amount of time spent waiting for treatment and the number of hospital visits for patients in the future.

Interventions

PROCEDURECone Beam CT

Patients will also have a CBCT scan when they are having their first IMRT treatment.

Sponsors

Princess Margaret Hospital, Canada
CollaboratorOTHER
University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with breast cancer who will receive standard two-field tangential whole breast radiation therapy with dose prescription of 4240 cGy in 16 fractions, 5000 cGy in 25 fractions or 4000 cGy in 16 fractions. * Patients with any stage of breast cancer. * Patients with prior treatment such as surgery or chemotherapy for any type of cancer. * Able to provide a written informed consent. * 18 years of age or older.

Exclusion criteria

* \< 18 years of age. * Unable to provide informed consent. * Males. * Patients who received partial breast radiation and not the standard dose. * Patients who will not receive 4240 cGy in 16 fractions, 5000 cGy in 25 fractions, or 4000 cGy in 16 fractions.

Design outcomes

Primary

MeasureTime frame
To generate on-line IMRT treatment plans using automated tools based on CBCT images acquired at the treatment unit.3 years

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026